C. Thompson

645 total citations · 1 hit paper
9 papers, 322 citations indexed

About

C. Thompson is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Economics and Econometrics. According to data from OpenAlex, C. Thompson has authored 9 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 2 papers in Infectious Diseases and 2 papers in Economics and Econometrics. Recurrent topics in C. Thompson's work include Advanced Breast Cancer Therapies (2 papers), HIV/AIDS Research and Interventions (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). C. Thompson is often cited by papers focused on Advanced Breast Cancer Therapies (2 papers), HIV/AIDS Research and Interventions (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). C. Thompson collaborates with scholars based in United States, Canada and United Kingdom. C. Thompson's co-authors include David Pérez-Rey, Jack London, Brecht Claerhout, Matvey B. Palchuk, John L. Esposito, Zuzanna Drebert, Jessamine Winer‐Jones, Kathleen Sherman‐Morris, Mona Loutfy and Denise Jaworsky and has published in prestigious journals such as Journal of Clinical Oncology, Antiviral Therapy and HIV Clinical Trials.

In The Last Decade

C. Thompson

8 papers receiving 319 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A global federated real-world data and analytics platform for research

2023 264 citations Matvey B. Palchuk, Jack London et al. JAMIA Open profile →

Peers

C. Thompson

EDM

EPIDE

SURGE

ID

CCM

Sali̇h Çeti̇ner Türkiye

Soumitra Ghosh India

Atanu Chandra India

Sarah John‐Olabode Nigeria

Ying Shao China

Oluwaseun E. Fashanu United States

Hei‐Tung Yip Taiwan

Silvia Guzmán Vázquez Mexico

Rola Khamisy‐Farah Israel

Sandra Ivic Switzerland

Sali̇h Çeti̇ner Türkiye

C. Thompson

20 ×0.3

EDM

82 ×1.5

EPIDE

50 ×0.9

SURGE

41 ×0.8

ID

26 ×0.7

CCM

Citations per year, relative to C. Thompson C. Thompson (= 1×) peers Sali̇h Çeti̇ner

Countries citing papers authored by C. Thompson

Since Specialization

Citations

This map shows the geographic impact of C. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Thompson more than expected).

Fields of papers citing papers by C. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Thompson. The network helps show where C. Thompson may publish in the future.

Co-authorship network of co-authors of C. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of C. Thompson. A scholar is included among the top collaborators of C. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Thompson. C. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

O’Rourke, Julia A., Zuzanna Drebert, C. Thompson, et al.. (2023). Exploring Breast Cancer Systemic Drug Therapy Patterns in Real-World Data. JCO Clinical Cancer Informatics. 7(7). e2300061–e2300061. 1 indexed citations

2.

Palchuk, Matvey B., Jack London, David Pérez-Rey, et al.. (2023). A global federated real-world data and analytics platform for research. JAMIA Open. 6(2). ooad035–ooad035. 264 indexed citations breakdown →

3.

West, Alex, Alexandra Lawrence, Hao Bao, et al.. (2023). Nebulised pirfenidone in non-idiopathic pulmonary fibrosis (IPF) progressive pulmonary fibrosis (PPF): first look at FVC data. PA405–PA405.

4.

London, Jack, et al.. (2023). Deriving breast cancer chemotherapy patterns from real-world data.. Journal of Clinical Oncology. 41(16_suppl). e13586–e13586. 1 indexed citations

5.

Goldin, Jonathan, et al.. (2022). Inhaled pirfenidone is associated with better quality of life scores in idiopathic pulmonary fibrosis. 4625–4625. 2 indexed citations

6.

Thompson, C., et al.. (2018). Evaluation of a clinic-based quality structure for Special Access Programme medicines to treat parasitic infections. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 3(3). 131–136. 1 indexed citations

7.

Thompson, C., et al.. (2012). Pet Ownership and the Spatial and Temporal Dimensions of Evacuation Decisions. Southeastern geographer. 52(3). 253–266. 17 indexed citations

8.

Jaworsky, Denise, C. Thompson, Mark H. Yudin, et al.. (2009). Use of Newer Antiretroviral Agents, Darunavir and Etravirine with or without Raltegravir, in Pregnancy: A Report of two Cases. Antiviral Therapy. 15(4). 677–680. 26 indexed citations

9.

Loutfy, Mona, Janet Raboud, C. Thompson, et al.. (2003). Clinical Impact of Double Protease Inhibitor Boosting with Lopinavir/Ritonavir and Amprenavir as Part of Salvage Antiretroviral Therapy. HIV Clinical Trials. 4(5). 301–310. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact